(Q33897249)

29 July 2017

1 reference

title

Lenograstim: an update of its pharmacological properties and use in chemotherapy-induced neutropenia and related clinical settings (English)

1 reference

29 July 2017

1 reference

C J Dunn

1

1 reference

29 July 2017

K L Goa

series ordinal

2

1 reference

29 July 2017

publication date

1 March 2000

1 reference

29 July 2017

1 reference

29 July 2017

volume

59

1 reference

29 July 2017

issue

3

1 reference

29 July 2017

page(s)

681-717

1 reference

Aplastic Anemia: Biology and Treatment

29 July 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200059030-00017

Biweekly COP-BLAM (cyclophosphamide, vincristine, prednisone, bleomycin, doxorubicin and procarbazine) regimen combined with granulocyte colony stimulating factor (G-CSF) for intermediate-grade non-Hodgkin's lymphoma.

21 January 2018

1 reference

12 December 2020

Glycosylation improves the priming effect exerted by recombinant human granulocyte colony-stimulating factor (lenograstim) on human neutrophil superoxide production

1 reference

12 December 2020

Recombinant granulocyte colony-stimulating factor administration to healthy volunteers: induction of immunophenotypically and functionally altered neutrophils via an effect on myeloid progenitor cells

1 reference

12 December 2020

Autografting in chronic myeloid leukaemia

1 reference

12 December 2020

Optimal schedule for administering granulocyte colony-stimulating factor in chemotherapy-induced neutropenia in non-small-cell lung cancer

1 reference

12 December 2020

Effect of lenograstim on the cost of autologous bone marrow transplantation. A preliminary communication

1 reference

12 December 2020

Economic analysis of lenograstim in the correction of neutropenia following chemotherapy for non-Hodgkin's lymphoma

1 reference

12 December 2020

Clinical and economic comparison of lenograstim-primed blood cells (BC) and bone marrow (BM) allogeneic transplantation

1 reference

12 December 2020

Randomised vehicle-controlled dose-finding study of glycosylated recombinant human granulocyte colony-stimulating factor after bone marrow transplantation.

1 reference

12 December 2020

Structural Characterization of Natural and Recombinant Human Granulocyte Colony-Stimulating Factors1

1 reference

12 December 2020

Phase I study of carboplatin, cisplatin, and cyclophosphamide without and with lenograstim for the treatment of ovarian cancer.

1 reference

12 December 2020

Mobilization and transplantation of Philadelphia-negative peripheral-blood progenitor cells early in chronic myelogenous leukemia

1 reference

12 December 2020

Marrow transplantation for aplastic anemia

1 reference

12 December 2020

An economic evaluation of the use of granulocyte colony-stimulating factor after bone marrow transplantation in children

1 reference

12 December 2020

Pharmacokinetics of glycosylated recombinant human granulocyte colony-stimulating factor (lenograstim) in healthy male volunteers

1 reference

12 December 2020

Hematological effect of 14 days treatment of recombinant human granulocyte colony-stimulating factor for neutropenia in myelodysplastic syndromes

1 reference

12 December 2020

Recombinant granulocyte colony-stimulating factor (rG-CSF). A review of its pharmacological properties and prospective role in neutropenic conditions

1 reference

12 December 2020

Beneficial effect of recombinant human glycosylated granulocyte colony-stimulating factor in marrow-transplanted patients: results of multicenter phase II-III studies

1 reference

12 December 2020

Clinical evaluation of recombinant human G-CSF in children with cancer

1 reference

12 December 2020

The use of granulocyte colony-stimulating factor to shorten the interval between cycles of mitomycin C, vindesine, and cisplatin chemotherapy in non-small-cell lung cancer

1 reference

12 December 2020

In vivo administration of granulocyte colony‐stimulating factor promotes neutrophil survival in vitro

1 reference

12 December 2020

Spontaneous rupture of spleen during peripheral blood stem-cell mobilisation in a healthy donor.

1 reference

12 December 2020

Physicochemical and biochemical characteristics of glycosylated recombinant human granulocyte colony stimulating factor (lenograstim).

1 reference

12 December 2020

Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils

1 reference

12 December 2020

Overview of the lenograstim pharmacoeconomics programme

1 reference

12 December 2020

Effects of in vivo administration of G-CSF on neutrophil functions in healthy volunteers

1 reference

12 December 2020

Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related febrile neutropenia.

1 reference

12 December 2020

Granulocyte colony-stimulating factor administration to healthy volunteers: analysis of the immediate activating effects on circulating neutrophils

1 reference

12 December 2020

Can cytotoxic dose-intensity be increased by using granulocyte colony-stimulating factor? A randomized controlled trial of lenograstim in small-cell lung cancer

1 reference

12 December 2020

Delaying treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for hematological malignancies: a prospective randomized trial

1 reference

12 December 2020

Recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF): an appraisal of its pharmacoeconomic status in neutropenia associated with chemotherapy and autologous bone marrow transplant

1 reference

12 December 2020

Autologous transplants for chronic myelogenous leukaemia: results from eight transplant groups

1 reference

12 December 2020

Phase I-II trial of intensification of the MAID regimen with support of lenograstim (rHuG-CSF) in patients with advanced soft-tissue sarcoma (STS)

1 reference

12 December 2020

Crossover study of the haematological effects and pharmacokinetics of glycosylated and non-glycosylated G-CSF in healthy volunteers

1 reference

12 December 2020

Apparent reactivation of a red cell alloantibody in a healthy individual after G-CSF administration

1 reference

12 December 2020

Sweet's syndrome induced by granulocyte colony-stimulating factor in a woman with congenital neutropenia

1 reference

12 December 2020

Economic evaluation of lenograstim (glycosylated rHuG-CSF) in the treatment of inflammatory breast cancer for Germany and Italy

1 reference

12 December 2020

Recombinant human granulocyte colony-stimulating factor can mobilize sufficient amounts of peripheral blood stem cells in healthy volunteers for allogeneic transplantation

1 reference

12 December 2020

Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy

1 reference

12 December 2020

Treatment of aplastic anaemia with antilymphocyte globulin and cyclosporin

1 reference

12 December 2020

Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia

1 reference

12 December 2020

Target cells for granulocyte colony-stimulating factor, interleukin-3, and interleukin-5 in differentiation pathways of neutrophils and eosinophils.

1 reference

12 December 2020

Rapid and complete hemopoietic reconstitution following combined transplantation of autologous blood and bone marrow cells. A changing role for high dose chemo-radiotherapy?

1 reference

12 December 2020

O-linked sugar chain of human granulocyte colony-stimulating factor protects it against polymerization and denaturation allowing it to retain its biological activity

1 reference

12 December 2020

Aplastic anemia (first of two parts): pathogenesis, diagnosis, treatment, and prognosis

1 reference

12 December 2020

Treatment of Felty's syndrome with the haemopoietic growth factor granulocyte colony-stimulating factor (G-CSF)

1 reference

12 December 2020

The gene for glycogen-storage disease type 1b maps to chromosome 11q23.

1 reference

12 December 2020

Lenograstim as support for ACE chemotherapy of small-cell lung cancer: a phase III, multicenter, randomized study

1 reference

12 December 2020

Effects of recombinant human granulocyte colony-stimulating factor on leucopenia in zidovudine-treated patients with AIDS and AIDS related complex, a phase I/II study

1 reference

12 December 2020

Optimal timing for collection of PBPC after glycosylated G-CSF administration

1 reference

12 December 2020

Prevention of febrile leucopenia after chemotherapy in high-risk breast cancer patients: no significant difference between granulocyte-colony stimulating growth factor or ciprofloxacin plus amphotericin B.

1 reference

12 December 2020

Efficacy of lenograstim on hematologic tolerance to MAID chemotherapy in patients with advanced soft tissue sarcoma and consequences on treatment dose-intensity

1 reference

12 December 2020

NCCN practice guidelines for fever and neutropenia. National Comprehensive Cancer Network

1 reference

12 December 2020

Low-dose versus standard-dose lenograstim prophylaxis after chemotherapy: a randomized, crossover comparison

1 reference

12 December 2020

Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis.

1 reference

12 December 2020

Treatment of the anemia of aplastic anemia patients with recombinant human erythropoietin in combination with granulocyte colony-stimulating factor: a multicenter randomized controlled study. Multicenter Study Group

1 reference

12 December 2020

Mobilisation of healthy donors with lenograstim and transplantation of HLA-genoidentical blood progenitors in 54 patients with hematological malignancies: a pilot study

1 reference

12 December 2020

Cost-minimization analysis of prophylactic granulocyte colony-stimulating factor after induction chemotherapy in children with non-Hodgkin's lymphoma

1 reference

12 December 2020

The optimal dose of glycosylated recombinant human granulocyte colony stimulating factor for use in clinical practice: a review.

1 reference

12 December 2020

Recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for non-small cell lung cancer

1 reference

12 December 2020

Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia

1 reference

12 December 2020

Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation

1 reference

12 December 2020

The effect of granulocyte colony-stimulating factor (G-CSF) on the degranulation of secondary granule proteins from human neutrophils in vivo may be indirect

1 reference

12 December 2020

Blood stem cell procurement: donor safety issues.

1 reference

12 December 2020

Peripheral blood stem cell transplantation as an alternative to autologous marrow transplantation in the treatment of acute myeloid leukemia?

1 reference

12 December 2020

Development of a simplified single-apheresis approach for peripheral-blood progenitor-cell transplantation in previously treated patients with lymphoma

1 reference

12 December 2020

A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia. AML Cooperative Study Group

1 reference

12 December 2020

Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells

1 reference

12 December 2020

Altered surface marker expression and function of G‐CSF‐induced neutrophils from test subjects and patients under chemotherapy

1 reference

12 December 2020

A randomized double-blind controlled study of recombinant human granulocyte colony-stimulating factor in patients with neutropenia induced by consolidation chemotherapy for acute myeloid leukemia. (rG.CSF clinical study group)

1 reference

12 December 2020

Economic evaluation of lenograstim for prophylaxis of chemotherapy-induced neutropenia in patients with small cell lung cancer

1 reference

12 December 2020

Mobilization of predominantly Philadelphia chromosome-negative blood progenitors using cyclophosphamide and rHUG-CSF in early chronic-phase chronic myeloid leukaemia: correlation with Sokal prognostic index and haematological control

1 reference

12 December 2020

The treatment of severe acquired aplastic anemia.

1 reference

12 December 2020

Mobilization of CD34+ cells by glycosylated and nonglycosylated G-CSF in healthy volunteers--a comparative study

1 reference

12 December 2020

The feasibility of using glycosylated recombinant human granulocyte colony-stimulating factor (G-CSF) to increase the planned dose intensity of doxorubicin, cyclophosphamide and etoposide (ACE) in the treatment of small cell lung cancer. Medical Res

1 reference

12 December 2020

Phase I study of accelerated FEC with granulocyte colony-stimulating factor (Lenograstim) support

1 reference

12 December 2020

Mobilization of Philadelphia-negative peripheral blood progenitor cells with chemotherapy and rhuG-CSF in chronic myelogenous leukaemia patients with a poor response to interferon-alpha

1 reference

12 December 2020

Placebo-controlled phase III study of lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) in aggressive non-Hodgkin's lymphoma: factors influencing chemotherapy administration. Groupe d'Etude des Lymphomes de l'Adulte.

1 reference

12 December 2020

Antilymphocyte globulin, cyclosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party

1 reference

12 December 2020

A European phase II study of recombinant human granulocyte colony-stimulating factor (lenograstim) in the treatment of severe chronic neutropenia in children. Lenograstim Study Group

1 reference

12 December 2020

Granulocyte colony-stimulating factor (G-CSF) increases neutrophil migration across vascular endothelium independent of an effect on adhesion: comparison with granulocyte-macrophage colony-stimulating factor (GM-CSF)

1 reference

12 December 2020

A single-blind, randomised, vehicle-controlled dose-finding study of recombinant human granulocyte colony-stimulating factor (lenograstim) in patients undergoing chemotherapy for solid cancers and lymphoma

1 reference

12 December 2020

A randomized controlled study of rG.CSF in patients with neutropenia after induction therapy for acute myelogenous leukemia. (rG.CSF Clinical Study Group)

1 reference

12 December 2020

Prospective Randomized Study Comparing the Efficacy of Bioequivalent Doses of glycosylated and nonglycosylated rG-CSF for Mobilizing Peripheral Blood Progenitor Cells

1 reference

12 December 2020

Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients

1 reference

12 December 2020

Recombinant granulocyte colony-stimulating factor (rG-CSF): pharmacoeconomic considerations in chemotherapy-induced neutropenia

1 reference

12 December 2020

Colony stimulating factors: G-CSFs--filgrastim (Neupogen) and lenograstim (Granocyte).

1 reference

12 December 2020

Effect of recombinant human granulocyte colony stimulating factor (lenograstim) on chemotherapy induced neutropenia in patients with urothelial cancer

1 reference

12 December 2020

Effective mobilization of Philadelphia-chromosome-negative cells in chronic myelogenous leukaemia patients using a less intensive regimen

1 reference

12 December 2020

NMR Investigations of the Role of the Sugar Moiety in Glycosylated Recombinant Human Granulocyte-Colony-Stimulating Factor

1 reference

12 December 2020

Development of acute myeloblastic leukaemia in a case of aplastic anaemia treated with granulocyte colony-stimulating factor

1 reference

12 December 2020

Progenitor-cell mobilization after low-dose cyclophosphamide and granulocyte colony-stimulating factor: an analysis of progenitor-cell quantity and quality and factors predicting for these parameters in 101 pretreated patients with malignant lymphom

1 reference

12 December 2020

Lenograstim. A review of its pharmacological properties and therapeutic efficacy in neutropenia and related clinical settings

1 reference

12 December 2020

Use and toxicity of the colony-stimulating factors

1 reference

12 December 2020

G-CSF after peripheral blood stem cell transplantation in lymphoma patients significantly accelerated neutrophil recovery and shortened time in hospital: results of a randomized BNLI trial

1 reference

12 December 2020

Autografting with philadelphia chromosome-negative mobilized hematopoietic progenitor cells in chronic myelogenous leukemia

1 reference

12 December 2020

Collection of Ph-negative progenitor cells with granulocyte-colony stimulating factor in patients with chronic myeloid leukaemia who respond to recombinant alpha-interferon

1 reference

12 December 2020

Ex vivo neutrophil function in response to three different doses of glycosylated rHuG-CSF (Lenograstim)

1 reference

12 December 2020

Effects of in vivo administration of G-CSF on neutrophil and eosinophil adhesion.

1 reference

12 December 2020

Recombinant human G-CSF (Lenograstim) for infectious complications in glycogen storage disease type Ib. Report of 7 cases

1 reference

12 December 2020

Placebo-controlled phase III trial of lenograstim in bone-marrow transplantation

1 reference

12 December 2020

A randomized controlled study of granulocyte colony stimulating factor after intensive induction and consolidation therapy in patients with acute lymphoblastic leukemia. Japan Adult Leukemia Study Group

1 reference

12 December 2020

A phase II trial of recombinant human granulocyte colony-stimulating factor in the myelodysplastic syndromes

1 reference

12 December 2020

Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: a randomized comparison

1 reference

12 December 2020

Lenograstim prevents morbidity from intensive induction chemotherapy in the treatment of inflammatory breast cancer

1 reference

12 December 2020

Clinical effect of recombinant human granulocyte colony-stimulating factor on aplastic anemia

1 reference

12 December 2020

From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever

1 reference

12 December 2020

Clinical evaluation of recombinant human granulocyte colony-stimulating factor (rhG-CSF) in autologous bone marrow transplantation

1 reference

12 December 2020

Blood and marrow transplantation activity in Europe 1997. European Group for Blood and Marrow Transplantation (EBMT).

1 reference

12 December 2020

A thermodynamic model for denaturation of granulocyte colony-stimulating factor: O-linked sugar chain suppresses not the triggering deprotonation but the succeeding denaturation

1 reference

12 December 2020

Escalating drug delivery in cancer chemotherapy: a review of concepts and practice--Part 2.

1 reference

12 December 2020

Update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based clinical practice guidelines. American Society of Clinical Oncology

1 reference

12 December 2020

10.2165/00003495-200059030-00017

Identifiers

DOI

1 reference

Dimensions Publication ID

29 July 2017

1039982658

0 references

1 reference